Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 76,330 | 38,870 |
| Marketable Securities | 0 | 0 | 0 | 46,470 | 1,010 |
| Receivables | 0 | 0 | 0 | 17,490 | 8,780 |
| Other current assets | 0 | 0 | 0 | 3,350 | 4,140 |
| TOTAL | $0 | $0 | $0 | $143,640 | $52,800 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 167,950 | 156,670 |
| Investments And Advances | 0 | 0 | 0 | 15,350 | 81,610 |
| Other Non-Current Assets | 0 | 0 | 0 | 8,050 | 7,500 |
| TOTAL | $N/A | $N/A | $N/A | $191,350 | $245,780 |
| Total Assets | $0 | $0 | $0 | $296,950 | $265,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,060 | 3,100 |
| Accrued Expenses | 0 | 0 | 0 | 29,550 | 16,480 |
| Other current liabilities | 0 | 0 | 0 | 6,450 | 3,350 |
| TOTAL | $0 | $0 | $0 | $37,470 | $23,670 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 19,050 | 18,040 |
| TOTAL | $N/A | $N/A | $N/A | $151,860 | $119,710 |
| Total Liabilities | $0 | $0 | $0 | $189,340 | $143,400 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 130 | 130 |
| Retained earnings | 0 | 0 | 0 | -262,770 | -247,830 |
| Other shareholders' equity | 0 | 0 | 0 | 329,110 | 332,280 |
| TOTAL | $0 | $0 | $0 | $107,600 | $122,180 |
| Total Liabilities And Equity | $0 | $0 | $0 | $296,940 | $265,580 |